{
    "nctId": "NCT06307249",
    "briefTitle": "Precision Therapy for Solid Tumors: Synergistic CDK4/6 Inhibition and Anti-VEGF Targeting LncRNA",
    "officialTitle": "Precision Therapy for Solid Tumors: Synergistic Inhibition of Cell Proliferation and Angiogenesis Via CDK4/6 and Anti-VEGF Approach Targeting LncRNA Expression",
    "overallStatus": "RECRUITING",
    "conditions": "Cancer, Solid Tumor, Colorectal Cancer, Breast Cancer, Ovarian Cancer, Lung Cancer, Targeted Therapy, Chemotherapy, Immunotherapy, Precision Therapy",
    "studyType": "INTERVENTIONAL",
    "phase": "PHASE1",
    "allocation": "RANDOMIZED",
    "primaryPurpose": "TREATMENT",
    "enrollmentCount": 50,
    "primaryOutcomeMeasure": "Assessment of Cancer Progression",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Individuals of white ethnicity.\n* Age between \\> 18\n* Both males and females.\n* Diagnosis of selected cancer type (e.g., colorectal cancer, lung cancer, genitourinary cancers, breast cancer).\n* Cancer stage III/ IV with or without metastasis or lymph node dissemination at the time of enrollment.\n* Unrelated patients.\n\nExclusion Criteria:\n\n* History of hematological cancer types or previous cancers, recurrent or relapse.\n* Diagnosis of inflammatory bowel diseases.\n* Pre-existing cardiovascular diseases or coronary artery diseases.\n* Confirmed treated or untreated autoimmune diseases.\n* Metabolic disorders, diabetes, or hypertension.\n* Neurological diseases.\n* Evidence of cardiac, renal, bone, or cerebral damage.\n* Presence of more than one type of malignancies.\n* Active infections or myositis.\n* Familial polyposis.\n* Alcohol or smoking habits.\n* Body mass index (BMI) \\>30.\n* Significant weight loss within the last 2 years.\n* History of surgeries.\n* Pregnancy.\n* Related patients.",
    "sex": "ALL",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}